SEC 13F Intelligence

Lion Point Capital, LP / RCKT

Lion Point Capital, LP’s Rocket Pharmaceuticals Inc Position

Does Lion Point Capital, LP own Rocket Pharmaceuticals Inc (RCKT)? Yes — 86.0K shares worth $307,880 (+1.84% of its 13F portfolio) as of Q1 2026.

Position Value
$307,880
Q1 2026
Shares
86.0K
% of Portfolio
+1.84%
Quarters Held
3
currently held

Position History RCKT

Reported value by quarter
Q3 ’25: $280,360Q3 ’25Q4 ’25: $301,860Q4 ’25Q1 ’26: $307,880Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202686.0K$307,880+1.84%
Q4 202586.0K$301,860+1.56%
Q3 202586.0K$280,360+1.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of RCKT.